Literature DB >> 15511527

In vitro and in vivo studies of F(0)F(1)ATP synthase regulation by inhibitor protein IF(1) in goat heart.

Francesca Di Pancrazio1, Irene Mavelli, Miriam Isola, Gianni Losano, Pasquale Pagliaro, David A Harris, Giovanna Lippe.   

Abstract

A method has been developed to allow the level of F(0)F(1)ATP synthase capacity and the quantity of IF(1) bound to this enzyme be measured in single biopsy samples of goat heart. ATP synthase capacity was determined from the maximal mitochondrial ATP hydrolysis rate and IF(1) content was determined by detergent extraction followed by blue native gel electrophoresis, two-dimensional SDS-PAGE and immunoblotting with anti-IF(1) antibodies. Anaesthetized open-chest goats were subjected to ischemic preconditioning and/or sudden increases of coronary blood flow (CBF) (reactive hyperemia). When hyperemia was induced before ischemic preconditioning, a steep increase in synthase capacity, followed by a deep decrease, was observed. In contrast, hyperemia did not affect synthase capacity when applied after ischemic preconditioning. Similar effects could be produced in vitro by treatment of heart biopsy samples with anoxia (down-regulation of the ATP synthase) or high-salt or high-pH buffers (up-regulation). We show that both in vitro and in vivo the same close inverse correlation exists between enzyme activity and IF(1) content, demonstrating that under all conditions tested the only significant modulator of the enzyme activity was IF(1). In addition, both in vivo and in vitro, 1.3-1.4 mol of IF(1) was predicted to fully inactivate 1 mol of synthase, thus excluding the existence of significant numbers of non-inhibitory binding sites for IF(1) in the F(0) sector.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15511527     DOI: 10.1016/j.bbabio.2004.07.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotection.

Authors:  Giovanna Lippe; Elena Bisetto; Marina Comelli; Stefania Contessi; Francesca Di Pancrazio; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

3.  Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics.

Authors:  Rossana Domenis; Marina Comelli; Elena Bisetto; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2011-09-01       Impact factor: 2.945

4.  Identification of a conserved calmodulin-binding motif in the sequence of F0F1 ATPsynthase inhibitor protein.

Authors:  Stefania Contessi; Francis Haraux; Irene Mavelli; Giovanna Lippe
Journal:  J Bioenerg Biomembr       Date:  2005-10       Impact factor: 2.945

Review 5.  Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.

Authors:  Opher S Kornfeld; Sunhee Hwang; Marie-Hélène Disatnik; Che-Hong Chen; Nir Qvit; Daria Mochly-Rosen
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

6.  The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1.

Authors:  Valentina Giorgio; Elena Bisetto; Raffaella Franca; David A Harris; Sabina Passamonti; Giovanna Lippe
Journal:  J Bioenerg Biomembr       Date:  2010-02-24       Impact factor: 2.945

Review 7.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

8.  Dimers of mitochondrial ATP synthase form the permeability transition pore.

Authors:  Valentina Giorgio; Sophia von Stockum; Manuela Antoniel; Astrid Fabbro; Federico Fogolari; Michael Forte; Gary D Glick; Valeria Petronilli; Mario Zoratti; Ildikó Szabó; Giovanna Lippe; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

9.  IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation.

Authors:  L Shen; L Zhi; W Hu; M X Wu
Journal:  Cell Death Differ       Date:  2008-12-19       Impact factor: 15.828

10.  IF(1) distribution in HepG2 cells in relation to ecto-F(0)F (1)ATPsynthase and calmodulin.

Authors:  Stefania Contessi; Marina Comelli; Sara Cmet; Giovanna Lippe; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2007-09-13       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.